Search

Search Constraints

You searched for: Author/Creator Guillerm, Gaelle

Search Results

1. Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). (26th November 2020)

2. Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery. Issue 1 (January 2014)

3. Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS. (17th October 2016)

4. Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide. (21st September 2021)

5. Impact of body‐surface area on patients' outcome in younger adults with acute myeloid leukemia. (1st March 2017)

6. Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase. Issue 12 (2nd December 2018)

7. Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. (2nd November 2022)

8. P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases. (20th September 2022)

9. Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms. Issue 1 (1st June 2020)

10. Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms. Issue 1 (1st June 2020)